<code id='184CB3AEA5'></code><style id='184CB3AEA5'></style>
    • <acronym id='184CB3AEA5'></acronym>
      <center id='184CB3AEA5'><center id='184CB3AEA5'><tfoot id='184CB3AEA5'></tfoot></center><abbr id='184CB3AEA5'><dir id='184CB3AEA5'><tfoot id='184CB3AEA5'></tfoot><noframes id='184CB3AEA5'>

    • <optgroup id='184CB3AEA5'><strike id='184CB3AEA5'><sup id='184CB3AEA5'></sup></strike><code id='184CB3AEA5'></code></optgroup>
        1. <b id='184CB3AEA5'><label id='184CB3AEA5'><select id='184CB3AEA5'><dt id='184CB3AEA5'><span id='184CB3AEA5'></span></dt></select></label></b><u id='184CB3AEA5'></u>
          <i id='184CB3AEA5'><strike id='184CB3AEA5'><tt id='184CB3AEA5'><pre id='184CB3AEA5'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:499
          Lee Klafczynski for STAT

          WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by.

          Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

          advertisement

          Politicians have been well aware of the problem for years. At the request of a large bipartisan group of lawmakers, a task force chaired by the Food and Drug Administration in 2019 reported on the root causes of drug shortages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

          DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

          IsnoonesafefromtheFTC?HasPfizerbottomedout?Andisbiotechfinallyback?Wecoverallthatandmorethisweekon“T